The non-protein amino acid L-b -ODAP (3-N-oxalyl-L-2,3diaminopropanoic acid, or its synonym b-N-oxalylamino-Lalanine, BOAA) has been proposed as a causative agent of the crippling disease termed neurolathyrism. 1,2) This is a human upper motoneuron disease disabling the legs of patients who had eaten grass pea (Lathyrus sativus L.) seeds for a substantial period of time as a major food source in some Asian and African countries. 3) L-b -ODAP is one of the major free amino acids of this draught-tolerant legume. As the etiology of neurolathyrism is still not well understood, it is of primary importance to understand the molecular mechanism inducing this upper motoneuron disease with sudden onset.
(AIDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ((S)-AMPA), (RS)-1-amino-5-phosphonoindan-1-carboxylic acid ((RS)-APICA), (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate ((2R,4R)-APDC), (RS)-a-cyclopropyl-4phosphonophenylglycine ((RS)-CPPG), L-(ϩ)-2-amino-4phosphonobutyric acid (L-AP4), 3,5-dimethyladamantan-1amine hydrochloride (memantine), (S)-2-methy-L-4-carboxypehnylglycine ((S)-MCPG), 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide (NBQX), 1-(4Ј-aminophenyl)-3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin-4-one (CFM-2), 2-methyl-6-(2-phenylethenyl)pyridine (SIB1893), L-(Ϫ)-threo-3-hydroxyaspartic acid, O-phospho-L-serine, L-quisqualic acid and L-b -ODAP were purchased from Tocris Cookson Inc. (MO, U.S.A.). (S)-(ϩ)-2,3-Diaminopropanoic acid (DAPA) was obtained from Tokyo Kasei Inc. (Tokyo, Japan). Kainic acid was obtained from Wako Pure Chemicals Inc. (Tokyo, Japan). Reagents for culturing cells were obtained from Gibco BRL (NY, U.S.A.).
[ 14 C]L-Glutamate was purchased from Moravek Biochemicals Inc. (CA, U.S.A.). All other chemicals were of the highest reagent grade and were purchased from Wako Pure Chemicals Inc. (Tokyo, Japan).
Cell Cultures The rat primary cortical cell culture was prepared according to the procedure of Dawson et al. 20) with slight modifications. Briefly, the cerebral cortices from 15 to 16 d old fetal rats were freed from meninges, and dispersed using 0.027% trypsin in a medium containing 25 mM glucose, 44 mM sucrose, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES) and phosphate buffered saline (PBS) (pH 7.4) followed by gentle trituration. Cells were plated onto polyornithine-treated 24-well polystyrene plates at a density of 4ϫ10 5 cells per well in modified Eagle's medium (MEM) containing 10% fetal bovine serum (FBS) and 10% horse serum. Glial cells were inhibited by 10 mg/ml 5-fluoro-2Ј-deoxyuridine on day 4. Cells were maintained in the MEM medium containing 5% horse serum for 14 to 18 d changing the media twice a week. Cells grown for 14 to 18 d were used.
Cytotoxicity Cells were freed of the treatment media and stained with 15 mM propidium iodide (PI) and 2 mg/ml of Hoechst 33342 in Hank's balanced salt solution. Stained cells were observed under a fluorescence microscope equipped with a CCD camera. The total number of neurons was counted from nuclei stained with Hoechst 33342, and the number of dead neurons was counted from those stained with PI strongly at their nuclei. At least 3000 cells were counted in each measurement. Cytotoxicity was measured using the method of Gonzalez-Zulueta et al. 21) and evaluated by percent cell death calculated by the following equation, and expressed as percent cell death: % cell deathϭ100ϫ(1Ϫ alive treated /alive control ), where, aliveϭ(1ϪPI-stained cells/ Hoechst 33342-stained cells). The number of cells was obtained by image analysis using NIH Image software.
Preparation of Xenopus Oocytes and Voltage-Clamp Recordings Adult female Xenopus laevis were chilled on ice, and the preparation and maintenance of the oocytes was carried out using methods similar to those described previously. 22) Group I mGluR clones (mGluR 1a , mGluR 1b , mGluR 5 ) [23] [24] [25] were donated by Dr. S. Nakanishi (Faculty of Medicine, Kyoto University, Kyoto, Japan) and clones of AMPA receptors (mouse glutamate receptor a 1 and a 2 ) 26) were donated by Dr. M. Mishina (Faculty of Medicine, University of Tokyo, Tokyo, Japan). Capped cRNAs were prepared using mRNA translation kits (Ambion, TX, U.S.A.). Xenopus laevis stage 5 or 6 oocytes were injected with 30 ng of mGluR 1a , 50 ng of mGluR 1a , or 30 ng of mGluR 5 cRNAs for group I mGluRs and 10 ng of a 1 and 20 ng of a 2 cRNAs for AMPA receptors. Following injection, the oocytes were incubated for 24-72 h in a medium ND96 (composition, concentrations in mM: NaCl 96, KCl 2, CaCl 2 1.8, MgCl 2 1, HEPES 5, pyruvate 2.5, pH 7.5) with 50 mg ml Ϫ1 gentamicin at 19°C until recordings were made. Macroscopic currents were recorded with a two-electrode voltage-clamp at a holding potential of Ϫ70 mV using a dual electrode voltage clamp amplifier CEZ-1250 (Nihon Koden, Tokyo, Japan). Electrodes were filled with 3 M KCl and had resistance of 0.4-3 MW. The oocytes were continuously superfused (2 ml min Ϫ1 ) with pyruvate-free ND96 solution.
[ 14 C]L-Glutamate Uptake by Xenopus Oocytes Expressing Cloned Glutamate Transporters The experiment was done as described previously. 27) EAAT clones, L-glutamate transporter 1 (GLT-1, GLL-1), and EAA carrier 1 (EAAC1) were donated by Dr. Y. Kanai (School of Medicine, Kyorin University, Japan). L-Glutamate/L-aspartate transporter (GLAST) clones were donated by Dr. S. Shimada (School of Medicine, Osaka University, Japan). cRNAs (30-50 ng) of respective glutamate transporters for EAAC1, GLAST and GLT-1 were injected per oocyte. The endogenous uptake activities for [ 14 C]L-glutamate of the oocytes without carrying cRNAs was 2-5% of those carrying GLAST, GLT-1, GLL-1, or EAAC1 cRNAs. Assays were performed at 22°C in triplicates 72 h after injection. Each assay tube (total 500 ml) contained 50 mM [ 14 C]L-glutamate (specific radioactivity; 2 mCi/mmol) and ND96 medium. Incubation was performed for 30 min at 22°C. The reaction was stopped by washing the oocytes with 1 ml of ice-cold ND96 medium three times. Cells were lysed with 1% sodium dodecyl sulfate (SDS), and radioactivity of the lysate was measured in a Packard TriCarb liquid scintillation spectrometer.
Statistical Analysis All data are shown as the meanϮS.E.M. of results obtained from four to six separate treatments to different cell preparations. Statistical analyses were performed using GraphPad Prism software (GraphPad software Inc., CA, U.S.A.). Differences among the means were analyzed using one-way analysis of variance (ANOVA), followed by Dunnett's multiple comparison tests. Probability (p) values less than 0.05 were considered statistically significant.
RESULTS

Characterization of the Effect of L-b b-ODAP on Rat Cortical Neuron/Glia Cultures
The effect of L-b -ODAP was investigated based on the PI dye-exclusion method using primary cortical cells from 15-16 d old fetal rats after 14 to 18 d in vitro (DIV). Various concentrations of L-b -ODAP were applied to the mixed neuron/glia cultures. Cytotoxicity indicated by strong PI staining of the nuclei was evident at concentrations of L-b -ODAP as low as 10 mM when treated for 24 h in a minimum medium with 25 mM glucose and 2% horse serum. Figure 1A shows neuronal death induced by various concentrations of L-b -ODAP. The highest toxicity (ca. 80% death compared to the control treatment) was observed with 300 mM of L-b -ODAP when treated for 24 h or 48 h. The 48 h exposure was slightly more toxic than that of 24 h. From this dose-dependency, 300 mM of L-b -ODAP was chosen as a standard, a highly toxic dose with which about 45 to 75% neurons died within the experimental period.
The specificity of action of L-b -ODAP in our system was analyzed by several antagonists acting on glutamate receptors of ionotoropic type by co-applying each antagonist with L-b -ODAP for 24 h (Fig. 1B) . A non-competitive AMPA receptor antagonist, CFM-2, a benzodiazepine derivative, partially inhibited the toxicity of L-b -ODAP at 50 mM (64.7Ϯ4.72% with 300 mM of L-b -ODAP vs. 19.6Ϯ4.77% with 300 mM of L-b -ODAP and 50 mM of CFM-2) in comparison with the stronger effect of the competitive inhibitor, NBQX (89% decrease of the toxicity of L-b -ODAP at 50 mM). On the other hand, memantine, which acts on the NMDA receptor channel as a blocker, did not affect the toxicity of L-b -ODAP. Memantine at this dose antagonized the toxicity induced by 300 mM of NMDA to cortical neurons almost completely (data not shown).
Effect of mGluR Agonists and Antagonists on L-b b-ODAP Toxicity Using this system, the involvement of mGluRs on L-b -ODAP toxicity was investigated. For this purpose, several mGluR agonists and antagonists were applied alone or with L-b -ODAP for 24 h and cell death were measured. Figure 2 shows some typical images of control (A) and drug-treated cells (B-F) after 24 h. The damaged neurons shrunk and had strong PI staining of the nuclei (Fig. 2B ).
As group I mGluR trigger the PI response and cause intracellular Ca 2ϩ increase and sometimes enhances cell death, effects of mGluR antagonists on the toxic effect of L-b -ODAP (300 mM) were examined. When AIDA (100 mM), a group I specific antagonist, was applied along with 300 mM of L-b -ODAP, cell death was partially and significantly decreased as shown in Fig. 2C; Fig. 3 . Similarly, MCPG (500 mM), an antagonist of both group I and II mGluR, also partially and significantly decreased the toxic effects of L-b -ODAP ( Fig. 2D; Fig. 3 ). Antagonists used in this experiment showed negligible toxicity towards neurons by themselves (AIDA; 8.95Ϯ0.83%, MCPG; 5.48Ϯ3.80 % cell death, respectively). SIB1893, a more specific antagonist towards subtype 5 of group I mGluR at 10 mM, also antagonized the toxicity of L-b -ODAP to a higher extent than the former two antagonists without toxicity itself (SIB1893 only; 2.24Ϯ 0.57% cell death) ( Fig. 3) . These results suggest that the toxicity of L-b -ODAP was partly derived from the activation of group I mGluRs. To confirm this assumption, the antagonists used here to inhibit group I mGluRs should not inhibit the AMPA receptor, because the activation of AMPA receptors by L-b -ODAP has been shown to induce neurotoxicity. 8) Therefore, we examined the direct effects of these antagonists on the AMPA receptors expressed in Xenopus oocytes. Neither 250 mM AIDA nor 500 mM MCPG inhibited the submaximal currents by 100 mM kainic acid (ca. 60% of the maximum) through AMPA receptors composed of a 1 and a 2 subunits, although MCPG slightly facilitated the currents ( Table 1) .
Effect of L-b b-ODAP on the Cl ؊ Current Triggered by the Expressed mGluR Clones in Xenopus Oocytes To investigate whether L-b -ODAP directly activated group I mGluR, we examined the effects of L-b -ODAP on group I mGluRs composed of mGluR 1a , mGluR 1b , or mGluR 5 subunits expressed in Xenopus oocytes. In this system, when the group I mGluRs were activated by an agonist, inositol-1,4,5trisphosphate was elevated followed by a rise in [Ca 2ϩ ] i . The [Ca 2ϩ ] i sensitive inward Cl Ϫ current was then observable by the voltage-clamp experiment. 23) In this system, 300 mM L-b -ODAP did not induce any currents in group I mGluRs composed of mGluR 5 subunits, although 100 mM L-glutamate or 50 mM L-quisqualate (the latter, not shown) induced nearly maximal currents (Fig. 4) . The same was true for the other group I mGluRs composed of mGluR 1a or mGluR 1b subunits (data not shown). Furthermore, 300 mM L-b -ODAP did not have any stimulatory or inhibitory effects on the half maximal currents induced by 10 mM L-glutamate (Table 2) .
In a separate set of experiments, the involvement of group II mGluR was analyzed. Effects of both agonists and antagonists were studied because the role of this subclass of receptors is unclear. When (RS)-APICA, a group II antagonist with a low toxicity dose at 100 mM (8.15Ϯ8.92% cell death) was applied along with L-b -ODAP, it did not change the toxicity of L-b -ODAP. The group II agonist (2R,4R)-APDC with a negligible toxicity dose at 30 mM (Ϫ9.71Ϯ5.27% cell death) slightly reduced the toxicity of L-b -ODAP without any significance (Fig. 3) .
Effect of L-b -ODAP on the third group of mGluR was also measured. In a similar experimental protocol as above, both 100 mM L-AP4, an atypical group III agonist, and 250 mM Ophospho-L-serine, a group III agonist, partially and significantly decreased the toxicity of L-b -ODAP ( Figs. 2E, F; Fig.  3 ). These chemicals hardly showed any toxicity towards neurons within these doses (O-phospho-L-serine; 3.85Ϯ3.96%, L-AP4; 2.26Ϯ1.95% cell death, respectively) by themselves. These results show that group III mGluR agonists also have a partial protecting effect against the toxicity of L-b -ODAP in cultured neurons.
Effect of L-b b-ODAP on Glutamate Transporters Expressed in Xenopus Oocytes
A previous report shows that the blockade of EAATs enhances activation of group I and group III metabotropic glutamate receptors. 28) We thus tried to examine the effect of L-b -ODAP on these molecules. For this purpose, three kinds of EAAT clones including GLT-1, EAAC1 and GLAST, were expressed in Xenopus oocytes, and [ 14 C]L-glutamate uptake was measured. As shown in Fig.  5 , L-(Ϫ)-threo-3-hydroxyaspartic acid, a competitive inhibitor almost completely inhibited these transporters. 1 mM L-b -ODAP partially inhibited [ 14 C]L-glutamate uptake into the oocytes expressing GLAST or EAAC1, while it did not inhibit GLL-1 (one species of GLT-1), the major transporterspecies in astroglia. A structurally relevant toxic compound DAPA, the de-oxalylation compound of L-b -ODAP also inhibited GLAST and EAAC1 stronger than L-b -ODAP, and also did not inhibit GLL-1.
DISCUSSION
Although previous reports including ours support the hypothesis that L-b -ODAP, the proposed causative agent of neu- rolathyrism, has a strong and specific action on AMPA-type glutamate receptors, 2,5) a small part of the neurotoxicity remains after treatment with NBQX or other antagonists acting on AMPA-type ionotropic, glutamatergic receptors in rat primary cortical neurons.
When several chemicals affecting mGluRs were applied to this system, we found that some of them reduced the neurotoxicity of L-b -ODAP. In the case of group I mGluRs, all three mGluR antagonists tested significantly lowered toxicity, indicating that L-b -ODAP had an influence on this receptor of primary cortical neuron. To justify this assumption, the group I mGluR antagonists used here should not inhibit AMPA receptors, whose activation by L-b -ODAP has been shown to induce neurotoxicity. 8) Therefore, we investigated the effects of these antagonists on AMPA receptors expressed in Xenopus oocytes. Neither 250 mM AIDA nor 500 mM MCPG inhibited the currents through AMPA receptors composed of a 1 and a 2 subunits, though the latter slightly facilitated them (Table 1 ). These results indicated that L-b -ODAP toxicity was partly derived from the activation of group I mGluRs. To elucidate whether there was direct interaction Xenopus oocytes injected with 10 ng of a 1 (GluR1) cRNA and 20 ng of a 2 (GluR2) cRNA were incubated for 72 h to express receptors in the ND96 medium at 19°C. Macroscopic currents evoked by 100 mM kainic acid were measured by a two-electrode voltage clamp experiment. The holding potential was Ϫ70 mV. The relative effects of co-applied 250 mM AIDA (nϭ4) or 500 mM MCPG (nϭ4) are shown as the meanϮS.E.M. The absolute current value with 100 mM kainic acid was ca. 260 nA and it was ca. 60% of the maximum current. Xenopus oocytes injected with 30 ng of mGluR 1a , 25 ng of mGluR 1b , or 27 ng of mGluR5 cRNA were incubated for 72 h to express receptor in ND96 medium at 19°C. Macroscopic current evoked by the activation by 10 mM L-glutamate was measured by a two-electrode voltage clamp experiment. The holding potential was Ϫ70 mV. The effects of co-application of 300 mM L-b -ODAP are shown as the mean percentageϮS.E.M. of the value without L-b -ODAP (nϭ4). The responses with 10 mM L-glutamate were ca. 50% of the maximum current for the three different clones. The absolute currents with 10 mM L-glutamate of mGluR 1a , mGluR 1b and mGluR 5 Fig. 4 . Effect of L-b -ODAP on Cloned mGlu 5 Receptor Expressed in Xenopus Oocytes Two days after rat mGluR 5 cRNA injection, the oocytes were subjected to a two-electrode voltage clamp experiment at a holding potential of Ϫ70 mV. 100 mM L-glutamate or 300 mM L-b -ODAP was applied to the same oocytes at the solid bar. L-b -ODAP did not induce any current, although L-glutamate induced a typical spastic response (about 400 nA). Xenopus oocytes were injected with cRNAs of GLL-1, EAC1 or GLAST, and incubated for 72 h. For the uptake experiment, oocytes were incubated with 50 mM [ 14 C]Lglutamate in ND96 medium at 22°C for 30 min as described in Materials and Methods. Data are averages of two independent experiments each done in triplicate and expressed as the percentage of the uptake of control experiment without competitors. The uptake without cRNA was subtracted from each measurement. between L-b -ODAP and group I mGluR, we studied the effect of L-b -ODAP on expressed group I mGluRs composed of mGluR 1a , mGluR 1b , or mGluR 5 subunits expressed in Xenopus oocytes. 300 mM L-b -ODAP (up to 1 mM) did not induce a current in type I mGluR composed of mGluR 5 subunits, although 100 mM L-glutamate induced nearly maximal currents (ca. 1 mA) (Fig. 4) . The same was true for the other group I mGluRs composed of mGluR 1a or mGluR 1b subunits. Furthermore, 300 mM L-b -ODAP did not have any stimulatory or inhibitory effects on the half maximal currents induced by 10 mM L-glutamate (Table 2) . These results suggest that L-b -ODAP did not directly activate group I mGluRs.
As to the group II mGluRs, both agonist, (2R,4R)-APDC and antagonist, (RS)-APICA did not show any effect on the toxicity of L-b -ODAP on this receptor group (Fig. 3) . Because of the toxicity of higher concentrations of these agents themselves, the range of concentrations used was limited. Within these limitations, the receptors seemed to have no effect on the neurotoxicity of L-b -ODAP in rat primary cortical neurons. Although MCPG acts on both group I and group II mGluRs as an antagonist, 29) the fact that MCPG was almost as effective as AIDA also excludes the possibility that group II mGluRs are involved in the neurotoxicity of L-b -ODAP.
The group III mGluR is known as an autoreceptor at the presynaptic site of the glutamatergic neuron, and its activation decreases cAMP levels. 30) Agonists acting on this receptor decreased the toxicity of L-b -ODAP (Fig. 3) . This suggests that the part of the toxic effect of L-b -ODAP might be a negative effect on group III mGluR activation, however, the effects of these agonists on the toxicity by L-b -ODAP were variable and rather weak. In addition, our preliminary results showed that (RS)-CPPG, a group III antagonist at 20 mM, also had a protective effect on L-b -ODAP toxicity (data not shown). Thus, the effects of both agonists and antagonists through group III mGluR were neuroprotective against L-b -ODAP toxicity. Further experiments are needed for the better understanding of the influence of group III mGluRs on the toxicity of L-b -ODAP.
As L-b -ODAP did not have any direct action on mGluRs, something might mediated the action of this neurotoxin. The most possible candidate for this role will be the endogenous L-glutamate. In fact, numerous reports show secondary excitotoxicities induced by the release of L-glutamate. 18, 31, 32) One aspect supporting this possibility is from our preliminary results on glutamate transporters. We measured the effect of Lb-ODAP on [ 14 C]L-glutamate uptake by Xenopus oocytes having expressed glutamate transporter molecules of three major types. As shown in Fig. 5, 1 mM L-b -ODAP inhibited [ 14 C]L-glutamate uptake by the expressed EAAC1 and GLAST, but did not inhibit that of GLL-1, a liver subtype of GLT-1. This result suggests that there is not a general effect on the L-glutamate sequestering system by the astrocytes, but rather a specific effect, including transporters of the neuronal subtypes EAAC1 (and GLAST). Similar effects by a nontransportable type of transporter inhibitor have been shown recently. 28) Our results show for the first time that mGluRs as well as ionotropic glutamate receptors were involved in the toxicity of L-b -ODAP causing neuronal death. The role of mGluRs on L-b -ODAP-induced neuronal death may be a modification of ionotoropic receptor responses. By the effects of antagonists for AMPA receptor and for mGluRs, there was an overlapping contribution for protecting neuronal death. One of the possibilities to explain the result is that at least group I mGluR was effective at the downstream of AMPA receptor to cause neuronal death although precise transmission mechanism or receptor topology is unknown.
